Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Gastroenterology | Family Medicine

Stomach Cancer Clinical Trials

A listing of Stomach Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


Alabama

Birmingham Alabama 35294
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

California

Los Angeles California 90095
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Stanford California 94305
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Stanford University School of Medicine
Stanford California 94305

A clinical trial seeking patients for a research study for the treatment of Stomach Cancer, Gastric (Stomach) Cancer, Neoplasm of Cardioesophageal Junction or Gastrointestinal Stromal Tumor (GIST)

Colorado

Denver Colorado 80218
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Florida

Ocala Florida 34471
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

St. Petersburg Florida 33705
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Illinois

Urbana Illinois 61801
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Massachusetts

Boston Massachusetts 02114
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Boston Massachusetts 02111
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Minnesota

Rochester Minnesota 55905
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Missouri

St. Louis Missouri 63110
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Nevada

Las Vegas Nevada 89135
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

New York

Buffalo New York 14263
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

North Carolina

Durham North Carolina 27710
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Ohio

Cleveland Ohio 44106
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Columbus Ohio 43210
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Pennsylvania

Philadelphia Pennsylvania 19111
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Pittsburgh Pennsylvania 15232
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Tennessee

Nashville Tennessee 37203
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Washington

MultiCare Health System
Tacoma Washington 98405

Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach

View More »

Wenatchee Washington 98801
Updated

A clinical research study of MM-111, Paclitaxel and Trastuzumab for the treatment of HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer or Stomach Cancer

Germany

HELIOS Klinikum Berlin-Buch, Klinik für Interdisziplinäre Onkologie
Berlin 13125

A clinical trial to evaluate treatments for patients with Colo-rectal Cancer, Stomach Cancer or Melanoma

Korea, Republic of

Inje University Haeundae Paik Hospital
Busan 612-896

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Kyungpook National University Medical Center
Daegu 702-210

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

National Cancer Center
Goyang-si, Gyeonggi-do 410-769

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Chonnam National University Hwasun Hospital
Jeollanam-do 519-763

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

View More »

Seoul St. Mary's Hospital
Seoul 137-701

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Yonsei University Severance Hospital
Seoul 120-752

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Asan Medical Center
Seoul 138-736

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Yonsei University Gangnam Severance Hospital
Seoul 135-720

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Korea University Guro Hospital
Seoul 152-703

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Samsung Medical Center
Seoul 135-710

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Ajou University Hospital
Suwon 443-380

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer